Ionis Pharmaceuticals Statistics
Total Valuation
IONS has a market cap or net worth of $6.98 billion. The enterprise value is $6.22 billion.
| Market Cap | 6.98B |
| Enterprise Value | 6.22B |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, before market open.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IONS has 145.97 million shares outstanding. The number of shares has increased by 1.96% in one year.
| Shares Outstanding | 145.97M |
| Shares Change (YoY) | +1.96% |
| Shares Change (QoQ) | +1.35% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 101.11% |
| Float | 144.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 90.91 |
| PS Ratio | 8.99 |
| Forward PS | 11.11 |
| PB Ratio | 23.54 |
| P/FCF Ratio | n/a |
| PEG Ratio | 25.70 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.37, with a Debt / Equity ratio of 4.87.
| Current Ratio | 7.37 |
| Quick Ratio | 6.75 |
| Debt / Equity | 4.87 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.21 |
Financial Efficiency
Return on equity (ROE) is -107.90% and return on invested capital (ROIC) is -22.36%.
| Return on Equity (ROE) | -107.90% |
| Return on Assets (ROA) | -13.20% |
| Return on Capital (ROIC) | -22.36% |
| Revenue Per Employee | $837,778 |
| Profits Per Employee | -$415,066 |
| Employee Count | 927 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 0.38 |
Taxes
In the past 12 months, IONS has paid $21.02 million in taxes.
| Income Tax | 21.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.78% in the last 52 weeks. The beta is 0.40, so IONS's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +13.78% |
| 50-Day Moving Average | 42.16 |
| 200-Day Moving Average | 45.64 |
| Relative Strength Index (RSI) | 59.70 |
| Average Volume (20 Days) | 1,740,769 |
Short Selling Information
The latest short interest is 9.52 million, so 6.52% of the outstanding shares have been sold short.
| Short Interest | 9.52M |
| Short Previous Month | 8.65M |
| Short % of Shares Out | 6.52% |
| Short % of Float | 6.58% |
| Short Ratio (days to cover) | 6.79 |
Income Statement
In the last 12 months, IONS had revenue of $776.62 million and -$384.77 million in losses. Loss per share was -$2.67.
| Revenue | 776.62M |
| Gross Profit | 766.68M |
| Operating Income | -389.10M |
| Pretax Income | -363.75M |
| Net Income | -384.77M |
| EBITDA | -254.76M |
| EBIT | -277.31M |
| Loss Per Share | -$2.67 |
Balance Sheet
The company has $2.21 billion in cash and $1.44 billion in debt, giving a net cash position of $762.23 million or $5.22 per share.
| Cash & Cash Equivalents | 2.21B |
| Total Debt | 1.44B |
| Net Cash | 762.23M |
| Net Cash Per Share | $5.22 |
| Equity (Book Value) | 296.52M |
| Book Value Per Share | 2.03 |
| Working Capital | 2.09B |
Cash Flow
In the last 12 months, operating cash flow was -$323.46 million and capital expenditures -$17.80 million, giving a free cash flow of -$341.26 million.
| Operating Cash Flow | -323.46M |
| Capital Expenditures | -17.80M |
| Free Cash Flow | -341.26M |
| FCF Per Share | -$2.35 |
Margins
Gross margin is 98.72%, with operating and profit margins of -50.10% and -49.54%.
| Gross Margin | 98.72% |
| Operating Margin | -50.10% |
| Pretax Margin | -46.84% |
| Profit Margin | -49.54% |
| EBITDA Margin | -32.80% |
| EBIT Margin | -35.71% |
| FCF Margin | -43.94% |
Dividends & Yields
IONS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.96% |
| Shareholder Yield | -1.96% |
| Earnings Yield | -5.51% |
| FCF Yield | -4.89% |
Analyst Forecast
The average price target for IONS is $61.33, which is 28.25% higher than the current price. The consensus rating is "Buy".
| Price Target | $61.33 |
| Price Target Difference | 28.25% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 18.00% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IONS has an Altman Z-Score of 1.57 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.57 |
| Piotroski F-Score | 3 |